PTHS · Pelthos Therapeutics Inc. · Proposed Sales
$21.48
+0.98 (+4.78%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 6
42.94K
Avg daily vol (3M)
59.06K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.